Product Information
PROCHLORPERAZINE 25 MG SUPP is a generic product labeled by Cosette Pharmaceuticals, Inc., priced at $4.8651 per EA under NDC 00713013512. Its NADAC has been published 584 times since Nov 28, 2013.
FDA first approved this application on Nov 24, 1993. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
25 mg/1
Manufacturer
Cosette Pharmaceuticals, Inc.NDC
00713013512
Classification
Generic
Dosage Form
SUPPOSITORY
Route
RECTAL
Effective Date
9/23/2026
Active Ingredients
PROCHLORPERAZINEApproval Type
Generic (ANDA)
FDA Application
ANDA040058FDA Approved
11/24/1993
TE Code
AB
On Market Since
11/30/1993
Pharmacological Classes
Price Statistics
The NADAC for PROCHLORPERAZINE 25 MG SUPP has been published 584 times since Nov 28, 2013, and over the history we have for it it has declined 39.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $4.8651 per EA |
|---|---|
| All-time high | $9.2396 (May 13, 2015) |
| All-time low | $4.7646 (Aug 19, 2026) |
| 52-week high | $6.5195 |
| 52-week low | $4.7646 |
| Median price | $7.4148 |
| Average price | $7.1634 |
| Largest weekly change | +24.0% (Oct 20, 2021) |
| Weeks tracked | 584 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Cosette Pharmaceuticals, Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Prochlorperazine market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Phenothiazine class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of PROCHLORPERAZINE 25 MG SUPP?
The current National Average Drug Acquisition Cost (NADAC) for PROCHLORPERAZINE 25 MG SUPP, manufactured by Cosette Pharmaceuticals, Inc., is $4.8651 per EA (NDC 00713013512), effective Sep 30, 2026.
How has the price of PROCHLORPERAZINE 25 MG SUPP changed over time?
Over the history we have for it, the NADAC for PROCHLORPERAZINE 25 MG SUPP has declined 39.2%. It has been tracked across 584 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for PROCHLORPERAZINE 25 MG SUPP?
Since Nov 28, 2013, the NADAC for PROCHLORPERAZINE 25 MG SUPP has ranged from a low of $4.7646 (Aug 19, 2026) to a high of $9.2396 (May 13, 2015), with a median of $7.4148 per EA.
Are there cheaper alternatives to PROCHLORPERAZINE 25 MG SUPP?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as PROCHLORPERAZINE 25 MG SUPP in a comparable dosage form, but none are currently priced below it.
Who manufactures PROCHLORPERAZINE 25 MG SUPP?
PROCHLORPERAZINE 25 MG SUPP (NDC 00713013512) is labeled by Cosette Pharmaceuticals, Inc., and CMS classifies it as a generic product.